Physician profile
Amit D Patel
NPI 1699944314
$5,498.91
in general payments reported to CMS, 2019-2025
39 companies · $1,023 in 2025
The $1,023 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,709 · 2020: $370 · 2021: $405 · 2022: $1,283 · 2023: $285 · 2024: $424 · 2025: $1,023.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,341 · Travel and Lodging: $290 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,341.24 |
| Travel and Lodging | $290.16 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $930.87 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $849.09 | 2019-2023 | Nucala |
| Astrazeneca Pharmaceuticals LP | $749.73 | 2019-2025 | Airsupra, Fasenra |
| Jazz Pharmaceuticals INC. | $261.28 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $229.60 | 2019-2022 | |
| Grifols USA, LLC | $195.85 | 2019-2025 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $179.35 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $177.80 | 2019-2024 | Dupixent |
| Genentech USA, INC. | $176.14 | 2019-2025 | Xolair |
| Harmony Biosciences LLC | $162.15 | 2022-2025 | |
| Advanced Respiratory, INC | $112.08 | 2019-2021 | |
| Insmed, INC. | $109.43 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $107.62 | 2021-2022 | |
| Resmed Corp | $100.17 | 2019-2025 | |
| Optinose US, INC. | $96.22 | 2019-2020 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $89.20 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $88.96 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $78.27 | 2022 | |
| Sunovion Pharmaceuticals INC. | $76.54 | 2019-2020 | |
| Genzyme Corporation | $74.60 | 2019-2025 | |
| Electromed, INC. | $73.58 | 2019-2022 | |
| Gilead Sciences, INC. | $65.38 | 2019 | |
| Circassia INC. | $59.64 | 2019 | |
| Inogen, INC. | $58.96 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Ani Pharmaceuticals, INC. | $58.81 | 2023-2024 | Purified Cortrophin Gel |
| Teva Pharmaceuticals USA, INC. | $45.43 | 2022 | |
| United Therapeutics Corporation | $39.98 | 2022 | |
| Amgen INC. | $34.36 | 2019-2025 | Tezspire |
| Viatris Specialty LLC | $34.00 | 2025 | Yupelri |
| Shire North American Group INC | $26.92 | 2019 | |
| Pharming Healthcare, INC. | $21.25 | 2022 | |
| Baxter Healthcare | $18.59 | 2022 | |
| Pulmonx Corporation | $18.59 | 2024 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Mallinckrodt Hospital Products INC. | $18.11 | 2023 | Acthar |
| Nabriva Therapeutics, Plc | $18.00 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.19 | 2019 | |
| Inari Medical, INC. | $16.88 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Pfizer INC. | $16.24 | 2019 | |
| Philips North America LLC | $12.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.